KTX-951 is a PROTAC targeting IRAK4 degradation ( DC 50 =18 nM). KTX-951 (10 mg/kg) shows the oral bioavailability (F%) of 22% in a rat model. KTX-951 has good anticancer potentialForm:SolidIC50& Target:IRAK4.
Specifications and Purity: ≥98%
Molecular Formula: C46H52F2N8O6
Molecular Weight: 850.95
- UPC:
- 42201826
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- K650190-1mg
- CAS:
- 2573298-36-7
- Product Size:
- 1mg
akash.verma@cenmed.com
(732) 447-1115





